NutriBand (NTRB) Net Income towards Common Stockholders (2016 - 2026)
NutriBand's (NTRB) quarterly Net Income towards Common Stockholders came in at -$880561.0 in Q3 2026, up 96.3% year-over-year from -$448573.7 in Q3 2025, and up 29.1% quarter-over-quarter from -$1.2 million in Q2 2026.
NutriBand (NTRB) Net Income towards Common Stockholders (2016 - 2026) Analysis & Trends
NutriBand has disclosed Net Income towards Common Stockholders across 11 years of filings, most recently posting -$880561.0 for Q3 2026.
- In Q3 2026, Net Income towards Common Stockholders rose 96.3% year-over-year to -$880561.0; the TTM figure through Jul 2026 stood at -$7.0 million (up 78.3% YoY), while the FY2026 annual figure was -$30.0 million, down 186.61% from the prior year.
- Net Income towards Common Stockholders came in at -$880561.0 for Q3 2026 at NutriBand, up from -$1.2 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$689989.0 in Q2 2022 to a low of -$23.8 million in Q3 2025.
- Average Net Income towards Common Stockholders over 5 years is -$3.0 million, with a median of -$1.4 million recorded in 2025.
- Year-over-year, Net Income towards Common Stockholders plunged 1296.36% in 2025 and jumped 96.3% in 2026.
- Over 5 years, Net Income towards Common Stockholders stood at -$1.1 million in 2022, then tumbled by 63.64% to -$1.8 million in 2023, then gained by 22.58% to -$1.4 million in 2024, then plunged by 184.18% to -$3.9 million in 2025, then jumped by 77.26% to -$880561.0 in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$880561.0 in Q3 2026, -$1.2 million in Q2 2026, and -$968059.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | -576.00 Mn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | -118.80 Mn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 46.85 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 69.61 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | 260.00 Mn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 24.70 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | -66.70 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 30.35 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | 1.97 Mn |
| 10 | NutriBand | 94.45 Mn | 91.03 Mn | 181,874.00 | -880,561.00 |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -880,561.00 |
| Apr 30, 2026 | -1.24 Mn |
| Jan 31, 2026 | -968,059.00 |
| Oct 31, 2025 | -3.87 Mn |
| Jul 31, 2025 | -23.81 Mn |
| Apr 30, 2025 | -1.39 Mn |
| Jan 31, 2025 | -5.52 Mn |
| Oct 31, 2024 | -1.36 Mn |
| Jul 31, 2024 | -1.71 Mn |
| Apr 30, 2024 | -1.90 Mn |
| Jan 31, 2024 | -1.88 Mn |
| Oct 31, 2023 | -1.76 Mn |
| Jul 31, 2023 | -829,173.00 |
| Apr 30, 2023 | -1.02 Mn |
| Jan 31, 2023 | -1.68 Mn |
| Oct 31, 2022 | -1.08 Mn |
| Jul 31, 2022 | -1.04 Mn |
| Apr 30, 2022 | -689,989.00 |
| Jan 31, 2022 | -3.77 Mn |
| Oct 31, 2021 | -1.77 Mn |
NutriBand Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NTRB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "NTRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NTRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();